• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症中的全身促炎反应。

The systemic pro-inflammatory response in sepsis.

机构信息

Center for Molecular Medicine, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

J Innate Immun. 2010;2(5):422-30. doi: 10.1159/000316286. Epub 2010 Jun 8.

DOI:10.1159/000316286
PMID:20530955
Abstract

The systemic inflammatory response syndrome (SIRS) is the predominantly cytokine-mediated, pro-inflammatory response of the host to invading pathogens and is considered the hallmark sign of sepsis. Molecular components of this response can be divided into cytokines, plasma cascades and acute phase proteins while the predominant cellular components are leukocytes and the endothelium. High-throughput genetic profiling studies have led to increased insights into leukocyte regulation during sepsis. New players in the pro-inflammatory cytokine network include interleukin-17, high-mobility group box-1 protein, macrophage migration inhibitory factor, the myeloid-related proteins Mrp8 and Mrp14, and soluble triggering receptor expressed on myeloid cells-1. Activation of coagulation with concurrent downregulation of anticoagulant systems and fibrinolysis are almost universally present in septic patients with SIRS. Increasing evidence points to an extensive cross-talk between inflammation and coagulation, in which the protease-activated cell receptors play an important role. Sepsis causes excessive activation of the complement system in which C5a plays a key part. Further dissection of the role of host-pathogen interactions, the cytokine network, the coagulation cascade, the complement system and their multidirectional interactions in sepsis will pave the way for new treatment targets that can modify the excessive and collective activation of all these systems.

摘要

全身炎症反应综合征(SIRS)是宿主对入侵病原体的主要以细胞因子介导的促炎反应,被认为是脓毒症的标志性特征。该反应的分子成分可分为细胞因子、血浆级联和急性期蛋白,而主要的细胞成分是白细胞和内皮细胞。高通量基因谱研究增加了对脓毒症期间白细胞调节的深入了解。促炎细胞因子网络中的新成员包括白细胞介素-17、高迁移率族蛋白-1 蛋白、巨噬细胞移动抑制因子、髓系相关蛋白 Mrp8 和 Mrp14 以及骨髓细胞表达的可溶性触发受体-1。在发生 SIRS 的脓毒症患者中,几乎普遍存在凝血激活同时抗凝系统和纤溶下调的现象。越来越多的证据表明炎症和凝血之间存在广泛的相互作用,其中蛋白酶激活的细胞受体起着重要作用。脓毒症会导致补体系统过度激活,其中 C5a 起着关键作用。进一步剖析宿主-病原体相互作用、细胞因子网络、凝血级联、补体系统及其在脓毒症中的多向相互作用,将为能够改变所有这些系统过度和集体激活的新治疗靶点铺平道路。

相似文献

1
The systemic pro-inflammatory response in sepsis.脓毒症中的全身促炎反应。
J Innate Immun. 2010;2(5):422-30. doi: 10.1159/000316286. Epub 2010 Jun 8.
2
Compartmentalization of the inflammatory response in sepsis and SIRS.脓毒症和全身炎症反应综合征中炎症反应的区室化
J Endotoxin Res. 2006;12(3):151-70. doi: 10.1179/096805106X102246.
3
Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate: evidence from human studies and animal models.固有免疫途径的遗传变异及其对全身炎症反应综合征/代偿性抗炎反应综合征争论的潜在贡献:来自人类研究和动物模型的证据。
J Innate Immun. 2010;2(5):381-94. doi: 10.1159/000314269. Epub 2010 Apr 30.
4
The coagulant response in sepsis and inflammation.脓毒症和炎症中的凝血反应。
Hamostaseologie. 2010 Jan;30(1):10-2, 14-6.
5
Coagulation and complement protein differences between septic and uninfected systemic inflammatory response syndrome patients.脓毒症患者与未感染的全身炎症反应综合征患者之间凝血和补体蛋白的差异。
J Trauma. 2007 May;62(5):1082-92; discussion 1092-4. doi: 10.1097/TA.0b013e31804d23e1.
6
Mediators of systemic inflammatory response syndrome and the role of recombinant activated protein C in sepsis syndrome.全身炎症反应综合征的介质及重组活化蛋白 C 在脓毒症综合征中的作用。
Infect Dis Clin North Am. 2011 Dec;25(4):835-50. doi: 10.1016/j.idc.2011.07.009. Epub 2011 Sep 9.
7
Inflammation, endothelium, and coagulation in sepsis.脓毒症中的炎症、内皮与凝血
J Leukoc Biol. 2008 Mar;83(3):536-45. doi: 10.1189/jlb.0607373. Epub 2007 Nov 21.
8
[Host inflammatory and anti-inflammatory response during sepsis].[脓毒症期间宿主的炎症和抗炎反应]
Pathol Biol (Paris). 2012 Oct;60(5):306-13. doi: 10.1016/j.patbio.2012.03.011. Epub 2012 Apr 28.
9
Inflammation and coagulation.炎症和凝血。
Crit Care Med. 2010 Feb;38(2 Suppl):S26-34. doi: 10.1097/CCM.0b013e3181c98d21.
10
Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.血管生成素-2在严重脓毒症中升高:与炎症介质的相关性。
Crit Care Med. 2007 Jan;35(1):199-206. doi: 10.1097/01.CCM.0000251640.77679.D7.

引用本文的文献

1
Dysregulation of Host-Pathogen Interactions in Sepsis: Host-Related Factors.脓毒症中宿主-病原体相互作用的失调:宿主相关因素。
Semin Respir Crit Care Med. 2024 Aug;45(4):469-478. doi: 10.1055/s-0044-1787554. Epub 2024 Jul 1.
2
Development of Nontoxic Peptides for Lipopolysaccharide Neutralization and Sepsis Treatment.用于中和脂多糖及治疗脓毒症的无毒肽的研发
ACS Pharmacol Transl Sci. 2024 May 21;7(6):1795-1806. doi: 10.1021/acsptsci.4c00033. eCollection 2024 Jun 14.
3
Ursodeoxycholic and chenodeoxycholic bile acids attenuate systemic and liver inflammation induced by lipopolysaccharide in rats.
熊去氧胆酸和鹅去氧胆酸可减轻大鼠体内脂多糖诱导的全身炎症和肝脏炎症。
Mol Cell Biochem. 2025 Jan;480(1):563-576. doi: 10.1007/s11010-024-04994-2. Epub 2024 Apr 5.
4
Systemic inflammatory response syndrome in patients with severe fever with thrombocytopenia syndrome: prevalence, characteristics, and impact on prognosis.发热伴血小板减少综合征患者全身炎症反应综合征:患病率、特征及对预后的影响。
BMC Infect Dis. 2024 Jan 30;24(1):149. doi: 10.1186/s12879-024-09026-4.
5
Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.通过将先天结构折叠引入药物来靶向 Toll 样受体驱动的全身炎症。
Nat Commun. 2023 Sep 29;14(1):6097. doi: 10.1038/s41467-023-41702-y.
6
Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model.双重抑制补体 C5 和 CD14 可减轻脐血模型中的炎症反应。
Pediatr Res. 2023 Aug;94(2):512-519. doi: 10.1038/s41390-023-02489-2. Epub 2023 Feb 1.
7
The importance of a sepsis layered early warning system for critical patients.脓毒症分层早期预警系统对重症患者的重要性。
Am J Transl Res. 2022 Aug 15;14(8):5229-5242. eCollection 2022.
8
Differential Internalization of Thrombin-Derived Host Defense Peptides into Monocytes and Macrophages.凝血酶衍生宿主防御肽在单核细胞和巨噬细胞中的差异内化。
J Innate Immun. 2022;14(5):418-432. doi: 10.1159/000520831. Epub 2021 Dec 22.
9
Hemodynamic dysfunction in neonatal sepsis.新生儿败血症的血液动力学功能障碍。
Pediatr Res. 2022 Jan;91(2):413-424. doi: 10.1038/s41390-021-01855-2. Epub 2021 Nov 24.
10
Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.COVID-19 中的免疫血栓形成:中性粒细胞胞外陷阱的影响。
Biomolecules. 2021 May 6;11(5):694. doi: 10.3390/biom11050694.